Advertisement

Epidemiology of Behçet Syndrome and Regional Differences in Disease Expression

  • Sebahattin Yurdakul
Chapter

Abstract

Behçet syndrome (BS) is more prevalent along the ancient trading route known as the “Silk Road,” extending from the Mediterranean to the countries in the Far East, where the prevalence of HLA-B5 (51) is relatively more frequent in the healthy population. This suggests that the possible causative agent(s), including genetic factors such as HLA-B51, might have had spread along this route. Seven cross-sectional and population-based field studies showed that the prevalence of BS was between 19 and 421 among 100,000 adolescent/adult population in Turkey. The lower three frequencies (19, 20, and 80/105) come from Thrace, the European part. The disease is less common in Western Europe, the USA, and in the rest of the world but perhaps not as rare as it had previously been thought. A recent study showed that BS was as frequent (7.1/105) as other vasculitic diseases – 9/105 for the combination of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg–Strauss syndrome – in a suburb of Paris, France. This chapter focuses on the epidemiological features of the field surveys of BS in Turkey and the rest of the globe as well as regional differences in some of the clinical and laboratory features. Gastrointestinal disease is frequent in patients from the Far East (especially Japan), while it is rather infrequent among those from Turkey. Moreover, a high frequency of both pathergy test positivity and being a carrier of HLA-B5 (51) is observed in patients from Japan and the Mediterranean countries, in contrast to the patients from the UK and the USA.

Keywords

Arthritis Behçet’s disease Behçet syndrome Disease expression Epidemiology Erythema nodosum Field survey Folliculitis Genital ulcer HLA-B5 (51) Oral ulceration Pathergy test Regional difference Uveitis 

References

  1. 1.
    Verity DH, Marr JE, Ohno S, et al. Behçet’s disease, the silk road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54:213–20.CrossRefGoogle Scholar
  2. 2.
    Demirhindi O, Yazici H, Binyildiz P, et al. Silivri Fener koyu ve yoresinde Behçet hastaligi sikligi ve bu hastaligin toplum icinde taranabilmesinde kullanabilecek bir yontem. Cerrahpasa Tip Fak Derg. 1981;12:509–14. (in Turkish).Google Scholar
  3. 3.
    Yurdakul S, Gunaydin I, Tuzun Y, et al. The prevalence of Behçet’s syndrome in a rural area in northern Turkey. J Rheumatol. 1988;15:820–2.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Idil A, Gurler A, Boyvat A, et al. The prevalence of Behçet’s disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol. 2001;9:325–31.CrossRefGoogle Scholar
  5. 5.
    Azizlerli G, Kose AA, Sarica R, et al. Prevalence of Behçet’s disease in Istanbul, Turkey. Int J Dermatol. 2003;42:803–6.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Cakir N, Dervis E, Benian O, et al. Prevalence of Behçet’s disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol. 2004;22(4 Suppl 34):S53–5.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Cakır N, Pamuk ON, Derviş E, et al. The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int. 2012;32:895–908.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Colgecen E, Ozyurt K, Ferahbas A, et al. The prevalence of Behçet’s disease in a city in Central Anatolia in Turkey. Int J Dermatol. 2015;54:286–9.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    O’Duffy JD. Suggested criteria for diagnosis of Behçet’s disease. J Rheumatol. 1974;1(Suppl 1):18, Abstract 32.Google Scholar
  10. 10.
    International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335:1078–80.Google Scholar
  11. 11.
    Ozen S, Karaaslan Y, Ozdemir O, et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol. 1998;25:2445–9.PubMedGoogle Scholar
  12. 12.
    Yazici H, Akokan G, Yalgin B, Muftuoglu A. A high prevalence of HLA-B5 in Behçet’s disease. Clin Exp Immunol. 1977;30:259–61.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Seyahi E, Tahir Turanli E, Mangan MS, Celikyapi G, Oktay V, Cevirgen D, et al. The prevalence of Behçet’s syndrome and familial Mediterranean fever HLA-B51 and MEVF gene mutations among ethnic Armenians living in Istanbul, Turkey. Clin Exp Rheumatol. 2010;28(4 Suppl 60):S67–75.PubMedGoogle Scholar
  14. 14.
    Al-Rawi ZS, Neda AH. Prevalence of Behçet’s disease among Iraqis. Adv Exp Med Biol. 2003;528:37–41.PubMedCrossRefGoogle Scholar
  15. 15.
    Davatchi F, Jamshidi AR, Banihashemi AT, et al. WHO-ILAR COPCORD study (stage 1, urban study) in Iran. J Rheumatol. 2008;35:1384–90.PubMedGoogle Scholar
  16. 16.
    Moghimi N, Davatchi F, Rahimi E, Saidi A, Rashadmanesh N, Moghimi S, et al. WHO-ILAR COPCORD study (stage 1, urban study) in Sanandaj, Iran. Clin Rheumatol. 2015;34:535–43.PubMedCrossRefGoogle Scholar
  17. 17.
    Al-Dalaan A, Al Ballaa S, Al Sukati M, Mousa M, Bahabri S, Biyari T. The prevalence of Behçet’s disease in Al Qassim region of Saudi Arabia. In: Hamza M, editor. Behçet’s disease. Tunis, Tunisia: Pub Adhoua; 1997. p. 170–2.Google Scholar
  18. 18.
    Li R, Sun J, Ren LM, et al. Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford). 2012;51:721–9.CrossRefGoogle Scholar
  19. 19.
    Chaaya M, Slim ZN, Habib RR, et al. High burden of rheumatic diseases in Lebanon: a COPCORD study. Int J Rheum Dis. 2012;15:136–43.PubMedCrossRefGoogle Scholar
  20. 20.
    Maldini C, Druce K, Basu N, LaValley MP, Mahr A. Exploring the variability in Behçet’s disease prevalence: a meta-analytical approach. Rheumatology (Oxford). 2018;57:185–95.CrossRefGoogle Scholar
  21. 21.
    Hatemi G, Esatoglu SN, Yurdakul S. Considerations in designing and interpreting prevalence studies for Behçet’s syndrome. Pol Arch Intern Med. 2018;128:148–9.PubMedGoogle Scholar
  22. 22.
    Krause I, Yankevich A, Fraser A, Rosner I, Mader R, Zisman D, et al. Prevalence and clinical aspects of Behçet’s disease in the north of Israel. Clin Rheumatol. 2007;26:555–60.PubMedCrossRefGoogle Scholar
  23. 23.
    Jaber L, Milo G, Halpern GJ, et al. Prevalence of Behçet’s disease in an Arab community in Israel. Ann Rheum Dis. 2002;61:365–6.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Klein P, Weinberger A, Altmann VJ, Halabi S, Fachereldeen S, Krause I. Prevalence of Behcet’s disease among adult patients consulting three major clinics in a Druze town in Israel. Clin Rheumatol. 2010;29:1163–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Yamamoto S, Toyokawa H, Matsubara J, et al. A nation wide survey of Behçet’s disease in Japan. Jpn J Ophthalmol. 1974;18:282–90.Google Scholar
  26. 26.
    Shimizu T, Ehrlich GE, Inaba G, Hayashi K. Behçet’s disease (Behçet’s syndrome). Semin Arthritis Rheum. 1979;8:223–60.PubMedCrossRefGoogle Scholar
  27. 27.
    Nakae K, Masaki F, Hashimoto T, Inaba G, Mochizuki M, Sakane T. Recent epidemiological features of Behçet’s disease in Japan. In: Wechsler B, Godeau P, editors. Behçet’s disease. Amsterdam: Excerpta Medica; 1993. p. 145–51.Google Scholar
  28. 28.
    Iwata D, Namba K, Kitaichi N, et al. Recent clinical features of Behçet’s disease in Hokkaido, Japan. Clin Exp Rheumatol. 2004;22(Suppl 34):S-48.Google Scholar
  29. 29.
    Mishima S, Masuda K, İzawa Y, et al. Behçet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc. 1979;76:225–79.Google Scholar
  30. 30.
    Goto H, Mochizuki M, Yamaki K, et al. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51:41–4.CrossRefGoogle Scholar
  31. 31.
    Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S. Epidemiological and clinical features of Behçet’s disease in Korea. Yonsei Med J. 1997;38:428–36.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Bang D, Lee JH, Lee ES, Lee S, Choi JS, Kim YK, et al. Epidemiologic and clinical survey of Behçet’s disease in Korea: the first multicenter study. J Korean Med Sci. 2001;16:615–8.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Kim JN, Kwak SG, Choe JY, Kim SK. The prevalence of Behçet’s disease in Korea: data from Health Insurance Review and Assessment Service from 2011 to 2015. Clin Exp Rheumatol. 2017;35 Suppl 108(6):38–42.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Chang NC. Rheumatic diseases in China. J Rheumatol. 1983;10(Suppl 10):41–4.Google Scholar
  35. 35.
    Kaneko F, Nakamura K, Sato M, Tojo M, Zheng X, Zhang JZ. Epidemiology of Behçet’s disease in Asian countries and Japan. Adv Exp Med Biol. 2003;528:25–9.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Mok CC, Cheung TC, Ho CT, et al. Behçet’s disease in southern Chinese patients. J Rheumatol. 2002;29:1689–93.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Mousa AR, Marafie AA, Rifai KM, Dajani AI, Mukhtar MM. Behçet’s disease in Kuwait, Arabia: a report of 29 cases and a review. Scand J Rheumatol. 1986;15:310–32.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Chen Y-C, Chang H-W. Clinical characteristics of Behçet’s disease in southern Taiwan. J Microbiol Immunol Infect. 2001;34:207–10.PubMedPubMedCentralGoogle Scholar
  39. 39.
    Yu KH, See LC, Kuo CF, Chou IJ, Chou MJ. Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care Res (Hoboken). 2013;65:244–50.CrossRefGoogle Scholar
  40. 40.
    See LC, Kuo CF, Chou IJ, et al. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. Semin Arthritis Rheum. 2013;43:381–6.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Madanat WY, Alawneh KM, Smadi MM, et al. The prevalence of Behçet’s disease in the north of Jordan: a hospital-based epidemiological survey. Clin Exp Rheumatol. 2017;35 Suppl 108(6):51–4.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Jankowski J, Crombie I, Jankowski R. Behçet’s syndrome in Scotland. Postgrad Med J. 1992;68:566–70.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Chamberlain MA. Behçet’s syndrome in 32 patients in Yorkshire. Ann Rheum Dis. 1977;36:491–9.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Kanecki K, Nitsch-Osuch A, Goryński P, Tarka P, Kutera A, Tyszko P. Behçet disease: a rare systemic vasculitis in Poland. Pol Arch Intern Med. 2017;127:652–6.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Ek L, Hedfors E. Behçet’s disease: a review and a report of 12 cases from Sweden. Acta Derm Venereol. 1993;73:251–4.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Mohammad A, Mandl T, Sturfelt G, Segelmark M. Incidence, prevalence and clinical characteristics of Behcet’s disease in southern Sweden. Rheumatology (Oxford). 2013;52:304–10.CrossRefGoogle Scholar
  47. 47.
    Crespo J, Ribeiro J, Jesus E, Moura A, Reis C, Porto A. Behçet’s disease: particular features at the central zone of Portugal. In: Wechsler B, Godeau P, editors. Behçet’s disease: international congress series 1037. Amsterdam: Exerpta Medica; 1993. p. 207–10.Google Scholar
  48. 48.
    Kappen JH, van Dijk EH, Baak-Dijkstra M, van Daele PL, Lam-Tse WK, van Hagen PM, van Laar JA. Behçet’s disease, hospital-based prevalence and manifestations in the Rotterdam area. Neth J Med. 2015;73:471–7.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Salvarani C, Pipitone N, Catanoso MG, et al. Epidemiology and clinical course of Behçet’s disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum. 2007;57:171–8.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Olivieri I, Leccese P, Padula A, Nigro A, Palazzi C, Gilio M, D’Angelo S. High prevalence of Behçet’s disease in southern Italy. Clin Exp Rheumatol. 2013;31(3 Suppl 77):28–31.PubMedPubMedCentralGoogle Scholar
  51. 51.
    Cartella S, Filippini M, Tincani A, Airo P. Prevalence of Behçet’s disease in the province of Brescia in northern Italy. Clin Exp Rheumatol. 2014;32(4 Suppl 84):S176.PubMedPubMedCentralGoogle Scholar
  52. 52.
    Gonzalez-Gay MA, Garcia-Porrua C, Branas F, et al. Epidemiologic and clinical aspects of Behçet’s disease in a defined area of Northwestern Spain, 1988–1997. J Rheumatol. 2000;27:703–7.PubMedPubMedCentralGoogle Scholar
  53. 53.
    Graña J, Sánchez-Meizoso MO, Galdo F. Epidemiological aspects of Behçet’s disease in Galicia. J Rheumatol. 2001;28:2565–6.PubMedPubMedCentralGoogle Scholar
  54. 54.
    Sanchez Burson J, Grandal Y, Mendoza M, Montero R, Rejon E, Marenco JL. Clinical characteristics, HLA antigen and mortality in Behçet’s syndrome in Spain. In: Olivieri I, Salvarani C, Cantini F, editors. 8th international congress on Behçet’s disease: program and abstracts. Milan: Prex; 1998. p. 102.Google Scholar
  55. 55.
    Papoutsis NG, Abdel-Naser MB, Altenburg A, et al. Prevalence of Adamantiades-Behçet’s disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin Exp Rheumatol. 2006;24(5 Suppl 42):S125.PubMedPubMedCentralGoogle Scholar
  56. 56.
    Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, et al. Population-based prevalence study of Behçet’s disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum. 2008;58:3951–9.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Mahr A, Guillevin L, Poissonnet M, Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg–Strauss syndrome in a French urban multiethnic population in 2000: a capture–recapture estimate. Arthritis Rheum. 2004;51:92–9.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Yazici H, Seyahi E, Yurdakul S. Behçet’s syndrome is not so rare: why do we need to know? Arthritis Rheum. 2008;58:3640–3.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    B’chir Hamzaoui S, Harmel A, Bouslama K, Abdallah M, Ennafaa M, M’rad S, et al. La maladie de Behçet en Tunisie. Étude clinique de 519 cas [Behçet’s disease in Tunisia. Clinical study of 519 cases]. Rev Med Interne. 2006;27:742–50.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Houman MH, Neffati H, Braham A, Harzallah O, Khanfir M, Miled M, Hamzaoui K. Behçet’s disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Clin Exp Rheumatol. 2007;25(4 Suppl 45):S58–64.PubMedPubMedCentralGoogle Scholar
  61. 61.
    Benamour S, Zeroual B, Alaoui FZ. Joint manifestations in Behçet’s disease. A review of 340 cases. Rev Rhum Engl Ed. 1998;65:299–307.PubMedPubMedCentralGoogle Scholar
  62. 62.
    Taarit CB, Ben Turki S, Ben Maïz H. Rheumatologic manifestations of Behçet’s disease: report of 309 cases. Rev Med Interne. 2001;22(11):1049–55.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Assaad-Khalil SH, Kamel FA, Ismail EA. Starting a regional registry for patients with Behçet’s disease in North West Nile Delta region in Egypt. In: Hamza M, editor. Behçet’s disease. Tunis, Tunisia: Pub Adhoua; 1997. p. 173–6.Google Scholar
  64. 64.
    Dia D, Dieng MT, Sy Ndiaye T, Fall S, Ndongo S, Diallo M, Moreira Diop T, Labou A, Ndiaye B. Behçet’s disease in Dakar (Senegal): epidemiological and clinical features. Dakar Med. 2003;48:64–7.PubMedPubMedCentralGoogle Scholar
  65. 65.
    Ndiaye M, Sow AS, Valiollah A, et al. Behçet’s disease in black skin. A retrospective study of 50 cases in Dakar. J Dermatol Case Rep. 2015;9:98–102.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Poon W, Verity DH, Larkin GL, et al. Behçet’s disease in patients of West African and Afro-Caribbean origin. Br J Ophthalmol. 2003;87:876–8.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Liozon E, Roussin C, Puéchal X, et al. Behçet’s disease in East African patients may not be unusual and is an HLA-B51 negative condition: a case series from Mayotte (Comoros). Joint Bone Spine. 2011;78:166–70.PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Ajose FO, Adelowo O, Oderinlo O. Clinical presentations of Behçet’s disease among Nigerians: a 4-year prospective study. Int J Dermatol. 2015;54:889–97.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Hirohata T, Kuratsune M, Nomura A, Jimi S. Prevalence of Behçet’s syndrome in Hawai. Hawaii Med J. 1975;34:244–6.PubMedPubMedCentralGoogle Scholar
  70. 70.
    O’Duffy JD. Summary of international symposium on Behçet’s disease. J Rheumatol. 1978;5:229–33.PubMedPubMedCentralGoogle Scholar
  71. 71.
    Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM. Epidemiology and clinical characteristics of Behçet’s disease in the US: a population-based study. Arthritis Rheum. 2009;61:600–4.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Yazici Y, Moses N. Clinical manifestations and ethnic background of patients with Behçet’s syndrome in a US cohort. Arthritis Rheum. 2007;56:S502.Google Scholar
  73. 73.
    Oliveira AC, Buosi AL, Dutra LA, de Souza AW. Behçet disease: clinical features and management in a Brazilian tertiary hospital. J Clin Rheumatol. 2011;17:416–20.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Sachetto Z, Mahayri N, Ferraz RH, Costallat LT, Bertolo MB. Behçet’s disease in Brazilian patients: demographic and clinical features. Rheumatol Int. 2012;32:2063–7.PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Cooper DA, Penny R. Behçet’s syndrome: clinical, immunological and therapeutic evaluation of 17 patients. Aust NZ J Med. 1974;4:585–96.CrossRefGoogle Scholar
  76. 76.
    Hemminki K, Bermajo LJ, Forsti A. The balance between heritable and environmental aetiology of human disease. Nat Rev Genet. 2006;7:958–65.PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Tanaka C, Matsuda T, Hayashi E, Imamura Y, Ozaki S. Clinical manifestations and course of 200 Japanese patients with Behçet’s disease. Adv Exp Med Biol. 2003;528:77–9.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Oshima Y, Shimizu T, Yokohari R, Matsumoto T, Kano K, Kagami T, Nagaya H. Clinical studies on Behçet’s syndrome. Ann Rheum Dis. 1963;22:36.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Fukuda Y, Watanabe I. Pathological studies on intestinal Behçet’s (entero-Behçet’s) disease. In: Dilsen N, Konice M, Ovul C, editors. Behçet’s disease, proceedings of an international symposium on Behçet’s disease. Amsterdam: Excerpta Medica; 1979. p. 90–5.Google Scholar
  80. 80.
    Adeeb F, Ugwoke A, Stack AG, Fraser AD. Associations of HLA-B alleles with Behçet’s disease in Ireland. Clin Exp Rheumatol. 2017;35 Suppl 104:22–3.PubMedGoogle Scholar
  81. 81.
    Yurdakul S, Tuzuner N, Yurdakul I, et al. Gastrointestinal involvement in Behçet’s syndrome: a controlled study. Ann Rheum Dis. 1996;55:208–10.PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Hatemi I, Esatoglu SN, Hatemi G, Erzin Y, Yazici H, Celik AF. Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet’s syndrome: a strobe-compliant observational study from a dedicated multidisciplinary center. Medicine (Baltimore). 2016;95:e3348.CrossRefGoogle Scholar
  83. 83.
    Dilsen N, Konice M, Ovul C, editors. Clinical evaluation of 106 cases of Behçet’s disease. Behçet’s disease. Proceedings of an international symposium on Behçet’s disease. Amsterdam: Excerpta Medica; 1979. p. 124–9.Google Scholar
  84. 84.
    Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet’s disease. Int J Dermatol. 2003;42:346–51.PubMedCrossRefPubMedCentralGoogle Scholar
  85. 85.
    Al-Rawi ZS, Sharquie KE, Khalifa SJ, Al-Hadithi FM, Munir JJ. Behçet’s disease in Iraqi patients. Ann Rheum Dis. 1986;45:987–90.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Shahram F, Davatchi F, Nadji A, Jamshidi A, Chams H, Chams C, Shafaie N, Akbarian M, Gharibdoost F. Recent epidemiological data on Behçet’s disease in Iran: the 2001 survey. Adv Exp Med Biol. 2003;528:31–6.PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Madanat W, Sharaiha Z, Khasawneh S, Zureikat H, Fayyad F. Gastro-intestinal manifestations of Behçet’s disease. Adv Exp Med Biol. 2003;528:455–7.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Hamdan A, Mansour W, Uthman I, Masri AF, Nasr F, Arayssi T. Behçet’s disease in Lebanon: clinical profile, severity and two-decade comparison. Clin Rheumatol. 2006;25:364–7.PubMedCrossRefPubMedCentralGoogle Scholar
  89. 89.
    Al-Dalaan A, al Balaa S, el Ramahi K, al-Kawi Z, Bohlega S, Bahabri S, et al. Behçet’s disease in Saudi Arabia. J Rheumatol. 1994;21:658–61.PubMedPubMedCentralGoogle Scholar
  90. 90.
    Ward EM, Woodward TA, Mazlumzadeh M, Calamia KT. Gastrointestinal disease in Behçet’s disease. Adv Exp Med Biol. 2003;528:459–64.PubMedCrossRefGoogle Scholar
  91. 91.
    Yazici Y, Schimmel E, Swearingen CJ. Behçet’s syndrome in the US: clinical characteristics, treatment and ethnic/racial differences in manifestations in 347 patients with BS. Arthritis Rheum. 2009;60(Suppl).Google Scholar
  92. 92.
    Kobayashi T, Kishimoto M, Tokuda Y, Schimmel E, Swearingen C, Yoshida K, Utsunomiya M, Yamamoto M, Yazici Y. Disease manifestations and treatment differences among Behçet’s syndrome patients in the United States and Japan. Ann Rheum Dis. 2009;68(SIII):609.Google Scholar
  93. 93.
    Rodríguez-Carballeira M, Alba MA, Solans-Laqué R, et al. Registry of the Spanish network of Behçet’s disease: a descriptive analysis of 496 patients. Clin Exp Rheumatol. 2014;32(Suppl. 84):S33–9.PubMedGoogle Scholar
  94. 94.
    Tuzun Y, Yazici H, Pazarli H, Yalcin B, Yurdakul S, Muftuoglu A. The usefulness of the nonspecific skin hyperreactivity (the pathergy test) in Behçet’s disease in Turkey. Acta Derm Venereol (Stockh). 1979;59:77–9.Google Scholar
  95. 95.
    Altac M, Tuzun Y, Yurdakul S, Binyildiz P, Yazici H. The validity of the pathergy test (non-specific skin hyperreactivity) in Behçet’s disease: a double blind study by independent observers. Acta Derm Venereol (Stockh). 1982;62:158–9.Google Scholar
  96. 96.
    Yazici H, Tuzun Y, Pazarli H, Yalcin B, Yurdakul S, Muftuoglu A. The combined use of HLA-B5 and pathergy test as diagnostic markers of Behçet’s disease in Turkey. J Rheumatol. 1980;7:206–10.PubMedGoogle Scholar
  97. 97.
    Davies PG, Fordham JN, Kirwan JR, Barnes CG, Dinning WJ. The pathergy test and Behçet’s syndrome in Britain. Ann Rheum Dis. 1984;43:70–3.PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Yazici H, Chamberlain MA, Tuzun Y, et al. A comparative study of the pathergy among Turkish and British patients with Behçet’s disease. Ann Rheum Dis. 1984;43:74–5.PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    Dilsen N, Konice M, Aral O, Ocal L, Inanc M, Gul A. Comparative study of the skin pathergy test with blunt and sharp needles in Behçet’s disease: confirmed specificity but decreased sensitivity with sharp needles. Ann Rheum Dis. 1993;52:823–5.PubMedPubMedCentralCrossRefGoogle Scholar
  100. 100.
    Ohno S, Aoki K, Sugiura S, Nakayama E, Itakura K, Aizawa M. HL-A5 and Behçet’s disease. Lancet. 1973;2:1383–4.CrossRefGoogle Scholar
  101. 101.
    Ohno S, Asanuma T, Sugiura S, et al. HLA-Bw51 and Behçet’s disease. JAMA. 1978;240:529.PubMedCrossRefGoogle Scholar
  102. 102.
    Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behçet’s disease. Arch Ophthalmol. 1982;100:1455–8.CrossRefGoogle Scholar
  103. 103.
    Gul A, Uyar FA, Inanc M, Ocal L, Barrett JH, Aral O, Konice M, Saruhan-Direskeneli G. A weak association of HLA-B∗2702 with Behçet’s disease. Genes Immun. 2002;3:368–72.PubMedCrossRefGoogle Scholar
  104. 104.
    Chang HK, Kim JW. The clinical features of Behçet’s disease in Yongdong districts: analysis of a cohort followed from 1997 to 2001. J Korean Med Sci. 2002;17:784–9.PubMedPubMedCentralCrossRefGoogle Scholar
  105. 105.
    Lennikov A, Alekberova Z, Goloeva R, Kitaichi N, Denisov L, Namba K, et al. Single center study on ethnic and clinical features of Behcet’s disease in Moscow, Russia. Clin Rheumatol. 2015;34:321–7.PubMedCrossRefGoogle Scholar
  106. 106.
    O’Duffy JD, Taswell HF, Elveback LR. HLA antigens in Behçet’s disease. J Rheumatol. 1974;3:1.Google Scholar
  107. 107.
    Moore SB, O’Duffy JD. Lack of association between Behçet’s disease and major histocompatibility complex II antigens in an ethnically diverse North American Caucasoid patient group. J Rheumatol. 1986;13:771–3.PubMedGoogle Scholar
  108. 108.
    Lewis KA, Graham EM, Stanford MR. Systematic review of ethnic variation in the phenotype of Behçet’s disease. Scand J Rheumatol. 2007;36:1–6.PubMedCrossRefGoogle Scholar
  109. 109.
    Kotake S, Namba K, Higashi K, Goda C, Ariga T, Ogawa A, Ohno S. The change of clinical manifestations of patients with Behçet’s disease in Japan. Adv Exp Med Biol. 2003;528:83–4.PubMedCrossRefGoogle Scholar
  110. 110.
    Yoshida A, Kawashima H, Motoyama Y, Shibui H, Kaburaki T, Shimizu K, et al. Comparison of patients with Behçet’s disease in the 1980s and 1990s. Ophthalmology. 2004;111:810–5.PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Bang D, Oh S, Lee K-H, Lee E-S, Lee S. Influence of sex on patients with Behçet’s disease in Korea. J Korean Med Sci. 2003;18:231–5.PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Wang LY, Zhao DB, Gu J, Dai SM. Clinical characteristics of Behçet’s disease in China. Rheumatol Int. 2010;30:1191–6.PubMedCrossRefPubMedCentralGoogle Scholar
  113. 113.
    Zhang Z, He F, Shi Y. Behçet’s disease seen in China: analysis of 334 cases. Rheumatol Int. 2013;33:645–8.PubMedCrossRefPubMedCentralGoogle Scholar
  114. 114.
    Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y. Behçet disease: evolution of clinical manifestations. Medicine (Baltimore). 2011;90:125–32.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Sebahattin Yurdakul
    • 1
  1. 1.Department of Medicine, Division of Rheumatology, Cerrahpasa Medical FacultyUniversity of IstanbulIstanbulTurkey

Personalised recommendations